SGEM#406: Homeward Bound…after a dose of Intranasal Fentanyl for Sickle Cell Vaso-occlusive Pain

1 trial

Studi estratti dal podcast di Dr. Ken Milne

  • 2023Intranasal Fentanyl and Discharge from the Emergency Department Among Children with Sickle Cell Disease and Vaso-occlusive PainEmergency & ResuscitationIn 400 children with sickle cell disease and vaso-occlusive pain in the emergency department, intranasal fentanyl was associated with higher odds of discharge home than no intranasal fentanyl.